New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics Expected to benefit proteomics research, ...

Proteomics software refers to computational tools and platforms designed to analyze, process, and interpret proteomic data. As proteomics research scales, it increasingly relies on sophisticated ...

Bruker Corporation and Switzerland-based Biognosys AG today announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. Financial details were not ...

>8000 quantified cell lysate proteins with 40-minute gradients >5000 quantified cell lysate proteins with 4.8-minute separations on Evosep One >5000 quantified proteins in just 10 ng of cell lysate ...

A. AIP on timsTOF Ultra 2: Significantly improved peptide and protein identification performance for single-cell proteomics and immunopeptidomics (work-in-progress) The new AIP enables highly ...

Bruker and Biognosys entered into a strategic partnership in which Bruker made a majority-ownership investment in Biognosys. Co-founder and CEO Oliver Rinner, PhD, and his leadership team will ...

Typically, protein identification and quantitation is accomplished by electrophoretic separation of protein mixtures on 2-D gels followed by mass spectrometric analysis of individual protein spots.

Dr. Simona talks about the latest improvements to processing ion mobility (IM) data with Biognosys software. Spectronaut 15 features significant improvements to the library-free directDIA workflow ...

SCHLIEREN, Switzerland and BILLERICA, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Biognosys AG and Bruker Corporation (Nasdaq: BRKR) today announced a strategic partnership, in which Bruker has made a ...